Related references
Note: Only part of the references are listed.Grad-CAM: Visual Explanations from Deep Networks via Gradient-Based Localization
Ramprasaath R. Selvaraju et al.
INTERNATIONAL JOURNAL OF COMPUTER VISION (2020)
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study
Shanu Modi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
Ole-Johan Skrede et al.
LANCET (2020)
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
Peter Strom et al.
LANCET ONCOLOGY (2020)
Deep learned tissue fingerprints classify breast cancers by ER/PR/Her2 status from H&E images
Rishi R. Rawat et al.
SCIENTIFIC REPORTS (2020)
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
Jakob Nikolas Kather et al.
NATURE MEDICINE (2019)
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
Gabriele Campanella et al.
NATURE MEDICINE (2019)
HER2 and Breast Cancer - A Phenomenal Success Story
Daniel F. Hayes
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Deep learning-based classification of mesothelioma improves prediction of patient outcome
Pierre Courtiol et al.
NATURE MEDICINE (2019)
Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer
Gil Shamai et al.
JAMA NETWORK OPEN (2019)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Predicting cancer outcomes from histology and genomics using convolutional networks
Pooya Mobadersany et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Deep learning based tissue analysis predicts outcome in colorectal cancer
Dmitrii Bychkov et al.
SCIENTIFIC REPORTS (2018)
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
Nicolas Coudray et al.
NATURE MEDICINE (2018)
Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis
Florence R. Wilson et al.
SYSTEMATIC REVIEWS (2018)
The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis
I. Roxanis et al.
BREAST CANCER RESEARCH (2018)
ImageNet Large Scale Visual Recognition Challenge
Olga Russakovsky et al.
INTERNATIONAL JOURNAL OF COMPUTER VISION (2015)
The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets
Takaya Saito et al.
PLOS ONE (2015)
Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival
Andrew H. Beck et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
Heikki Joensuu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Risk for distant recurrence of breast cancer detected by mammography screening or other methods
H Joensuu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
A web-based system for individualised survival estimation in breast cancer
J Lundin et al.
BRITISH MEDICAL JOURNAL (2003)
Share Paper
